Advertisement
Table 1 Events prior to 1st January 2016 that potentially affected prescription rates
| Event date | Event |
|---|---|
| May 1997 | Donepezil first recorded in CPRD |
| September 1998 | Rivastigmine first recorded in CPRD |
| January 2001 | Galantamine first recorded in CPRD and first NICE guidance released |
| December 2002 | Memantine first recorded in CPRD |
| November 2006 | NICE recommended restricting drug access |
| September 2007 | QOF revised to include dementia |
| February 2009 | First National Dementia Strategy launched |
| March 2011 | NICE removed recommendation restricting drug access |
| January 2012 | Galantamine patent expired |
| February 2012 | Donepezil patent expired |
| May 2012 | Prime Minister’s Dementia Challenge launched |
| July 2012 | Rivastigmine patent expired |
| April 2014 | Memantine patent expired |
| February 2015 | Prime Minister’s Challenge on Dementia 2020 launched |
